CIK: 1350416 - Address: 4275 Executive Square, Suite 950, La Jolla, CA 92037
16 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret2141-1128616325
P%wins25757525505050
S%ret11110261217-36
S%wins73735545405056

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/24/15 13:02
12/23/15
AXSMAxsome Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallNYOChief MeP99.0311206I49-2-3329-9-21-26
9/13/11 17:01
9/9/11
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-2752.756-100-5678D263-32-23-269-2-2-1-28-24
1/7/11 17:23
1/5/11
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-414.0511-10-5178D8261202828-1121315-2-5-17-48
12/8/10 12:33
12/6/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-383.8016-10-5190D999106564334-16-9-5-1-3103-2-34
11/8/10 21:26
11/5/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-484.7631-10-5200D99915876464348777-4-4-23-17-18-45
10/5/10 20:25
10/5/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-323.236-10-4240D4446524815195-307413125-15
9/8/10 21:48
9/7/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-272.704-10-4251D192383323-19-13-7-5-1-11642291
8/20/10 19:18
8/18/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-1083.084-35-12261D220415924-10-7-8-4-50-14931-8
8/9/10 19:01
8/5/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-333.285-10-3296D2535187272211-2-1-5-1746243
7/9/10 17:34
7/7/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-303.025-10-3306D2347072937151946-1-2-5265
6/8/10 20:21
6/7/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-1192.383-50-14317D86962615-25-16-3-8122341217684
9/15/09 21:18
9/11/09
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieP42.18421398I-414538039314139-100-13027
9/15/09 21:18
9/15/09
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieS-42.104-20398I-414538039314139-100-13027
2/25/09 15:37
2/23/09
AVNRAvanir PharmaceuticalsCAHealthDrugPharmaceutical PreparationsKaye RandallCAOSVP,ChieP40.42630102426S-2-110150332316
1/22/08 19:41
5/8/06
AVNRAvanir PharmaceuticalsCAHealthDrugPharmaceutical PreparationsKaye RandallCAOChief MeM.d10.04000133420I-93-53-50-49-33-13-7-7-16156-13-47
5/26/06 14:41
5/26/06
AVNRAvanir PharmaceuticalsCAHealthDrugPharmaceutical PreparationsKaye RandallCAOVP of MeP2510.09432004b105-27-16-67-65

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact